nodes	percent_of_prediction	percent_of_DWPC	metapath
Silodosin—ADRA1A—Endothelin Pathways—ADCY10—nephrolithiasis	0.0467	0.0804	CbGpPWpGaD
Silodosin—ADRA1D—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0263	0.0453	CbGpPWpGaD
Silodosin—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.0259	0.0619	CcSEcCtD
Silodosin—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.0255	0.0608	CcSEcCtD
Silodosin—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.025	0.0597	CcSEcCtD
Silodosin—Purpura—Hydrochlorothiazide—nephrolithiasis	0.0241	0.0574	CcSEcCtD
Silodosin—UGT2B7—Phase II conjugation—SLC26A1—nephrolithiasis	0.0237	0.0408	CbGpPWpGaD
Silodosin—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.023	0.0549	CcSEcCtD
Silodosin—ADRA1D—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0221	0.0381	CbGpPWpGaD
Silodosin—ADRA1B—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0218	0.0376	CbGpPWpGaD
Silodosin—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.0214	0.0511	CcSEcCtD
Silodosin—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.0212	0.0506	CcSEcCtD
Silodosin—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.021	0.05	CcSEcCtD
Silodosin—ADRA1A—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0194	0.0334	CbGpPWpGaD
Silodosin—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.0185	0.0441	CcSEcCtD
Silodosin—ADRA1B—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0184	0.0316	CbGpPWpGaD
Silodosin—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.0174	0.0416	CcSEcCtD
Silodosin—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.0168	0.04	CcSEcCtD
Silodosin—ADRA1A—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0163	0.0281	CbGpPWpGaD
Silodosin—ADRA1D—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0161	0.0278	CbGpPWpGaD
Silodosin—UGT2B7—NRF2 pathway—SLC2A9—nephrolithiasis	0.0158	0.0272	CbGpPWpGaD
Silodosin—UGT2B7—Biological oxidations—SLC26A1—nephrolithiasis	0.0138	0.0238	CbGpPWpGaD
Silodosin—ADRA1B—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0134	0.023	CbGpPWpGaD
Silodosin—Syncope—Hydrochlorothiazide—nephrolithiasis	0.0125	0.0299	CcSEcCtD
Silodosin—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.0123	0.0295	CcSEcCtD
Silodosin—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.0123	0.0293	CcSEcCtD
Silodosin—ADRA1A—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0119	0.0205	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Other—CHRM3—nephrolithiasis	0.0117	0.0201	CbGpPWpGaD
Silodosin—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.0116	0.0278	CcSEcCtD
Silodosin—Shock—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0268	CcSEcCtD
Silodosin—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0111	0.0266	CcSEcCtD
Silodosin—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0254	CcSEcCtD
Silodosin—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0246	CcSEcCtD
Silodosin—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00932	0.0222	CcSEcCtD
Silodosin—ADRA1D—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00909	0.0156	CbGpPWpGaD
Silodosin—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00906	0.0216	CcSEcCtD
Silodosin—ABCB4—Metabolism—GRHPR—nephrolithiasis	0.00905	0.0156	CbGpPWpGaD
Silodosin—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00901	0.0215	CcSEcCtD
Silodosin—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00818	0.0195	CcSEcCtD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00813	0.014	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—AGXT—nephrolithiasis	0.00807	0.0139	CbGpPWpGaD
Silodosin—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00807	0.0192	CcSEcCtD
Silodosin—ADRA1D—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00788	0.0136	CbGpPWpGaD
Silodosin—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.0078	0.0186	CcSEcCtD
Silodosin—ADRA1B—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00754	0.013	CbGpPWpGaD
Silodosin—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00754	0.018	CcSEcCtD
Silodosin—Rash—Hydrochlorothiazide—nephrolithiasis	0.00719	0.0172	CcSEcCtD
Silodosin—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00718	0.0171	CcSEcCtD
Silodosin—Headache—Hydrochlorothiazide—nephrolithiasis	0.00714	0.017	CcSEcCtD
Silodosin—ABCB4—Metabolism—SLC26A1—nephrolithiasis	0.00686	0.0118	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—APRT—nephrolithiasis	0.00686	0.0118	CbGpPWpGaD
Silodosin—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00677	0.0162	CcSEcCtD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00674	0.0116	CbGpPWpGaD
Silodosin—ADRA1A—G alpha (q) signalling events—DGKH—nephrolithiasis	0.0067	0.0115	CbGpPWpGaD
Silodosin—ADRA1D—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00657	0.0113	CbGpPWpGaD
Silodosin—ADRA1B—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00654	0.0113	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00599	0.0103	CbGpPWpGaD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00588	0.0101	CbGpPWpGaD
Silodosin—ADRA1A—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00581	0.01	CbGpPWpGaD
Silodosin—ADRA1B—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00545	0.00939	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00508	0.00874	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—AQP1—nephrolithiasis	0.00489	0.00842	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00488	0.00839	CbGpPWpGaD
Silodosin—ADRA1A—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00484	0.00834	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—CHRM3—nephrolithiasis	0.00442	0.00761	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00435	0.00749	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00433	0.00746	CbGpPWpGaD
Silodosin—ADRA1B—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00421	0.00725	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—RGS14—nephrolithiasis	0.00383	0.0066	CbGpPWpGaD
Silodosin—ADRA1A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00374	0.00644	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00361	0.00622	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—RGS14—nephrolithiasis	0.00348	0.00599	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—CHRM3—nephrolithiasis	0.00331	0.0057	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00328	0.00565	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00328	0.00565	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00321	0.00552	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—RGS14—nephrolithiasis	0.00318	0.00548	CbGpPWpGaD
Silodosin—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.00318	0.00548	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—GRHPR—nephrolithiasis	0.00313	0.00538	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—PTH—nephrolithiasis	0.00303	0.00522	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00293	0.00504	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—RGS14—nephrolithiasis	0.00289	0.00497	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—RGS14—nephrolithiasis	0.00283	0.00487	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—AGXT—nephrolithiasis	0.00279	0.00479	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—CHRM3—nephrolithiasis	0.00275	0.00473	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00268	0.00461	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00268	0.00461	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—DGKH—nephrolithiasis	0.00259	0.00446	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—RGS14—nephrolithiasis	0.00257	0.00442	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—PTH—nephrolithiasis	0.00251	0.00433	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—CHRM3—nephrolithiasis	0.00244	0.0042	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—ADCY10—nephrolithiasis	0.00242	0.00416	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—SLC26A1—nephrolithiasis	0.00237	0.00408	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—APRT—nephrolithiasis	0.00237	0.00408	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—DGKH—nephrolithiasis	0.00235	0.00405	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—PTH—nephrolithiasis	0.00223	0.00385	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—DGKH—nephrolithiasis	0.00215	0.0037	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—RGS14—nephrolithiasis	0.00206	0.00354	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00203	0.00349	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00203	0.00349	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ADCY10—nephrolithiasis	0.00201	0.00346	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—DGKH—nephrolithiasis	0.00195	0.00336	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—DGKH—nephrolithiasis	0.00191	0.00329	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00188	0.00324	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00188	0.00324	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00187	0.00322	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ADCY10—nephrolithiasis	0.00178	0.00307	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—DGKH—nephrolithiasis	0.00173	0.00298	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—PTH—nephrolithiasis	0.00171	0.00295	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—RGS14—nephrolithiasis	0.00171	0.00294	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—CHRM3—nephrolithiasis	0.0017	0.00293	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—AQP1—nephrolithiasis	0.00169	0.00291	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00168	0.00289	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00168	0.00289	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—PTH—nephrolithiasis	0.00155	0.00268	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00155	0.00267	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—CHRM3—nephrolithiasis	0.00153	0.00263	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—RGS14—nephrolithiasis	0.00152	0.00261	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—PTH—nephrolithiasis	0.00142	0.00245	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—CHRM3—nephrolithiasis	0.00141	0.00243	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00139	0.00239	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—DGKH—nephrolithiasis	0.00139	0.00239	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00138	0.00238	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00134	0.00231	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—PTH—nephrolithiasis	0.00129	0.00222	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—PTH—nephrolithiasis	0.00126	0.00217	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—CHRM3—nephrolithiasis	0.00125	0.00216	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.00116	0.00201	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—DGKH—nephrolithiasis	0.00115	0.00198	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00115	0.00198	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—PTH—nephrolithiasis	0.00115	0.00197	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—AGXT—nephrolithiasis	0.00104	0.00179	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00102	0.00176	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—DGKH—nephrolithiasis	0.00102	0.00176	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CHRM3—nephrolithiasis	0.001	0.00173	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PTH—nephrolithiasis	0.000919	0.00158	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—APRT—nephrolithiasis	0.000883	0.00152	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—SLC26A1—nephrolithiasis	0.000883	0.00152	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CHRM3—nephrolithiasis	0.000834	0.00143	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PTH—nephrolithiasis	0.000762	0.00131	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CHRM3—nephrolithiasis	0.00074	0.00127	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.000718	0.00124	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PTH—nephrolithiasis	0.000677	0.00117	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.00064	0.0011	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—AQP1—nephrolithiasis	0.000629	0.00108	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CHRM3—nephrolithiasis	0.000569	0.000979	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—APRT—nephrolithiasis	0.000544	0.000936	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	0.000544	0.000936	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—SPP1—nephrolithiasis	0.000461	0.000794	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—AQP1—nephrolithiasis	0.000388	0.000667	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—SPP1—nephrolithiasis	0.000383	0.000659	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CHRM3—nephrolithiasis	0.000351	0.000603	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SPP1—nephrolithiasis	0.00034	0.000585	CbGpPWpGaD
